| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |